bioRxiv ScienceSearch

bioRxiv · 10.1101/567263

A decade of empirical research on research integrity: what have we (not) looked at?

Abstract

In the past decades, increasing visibility of research misconduct scandals created momentum for discourses on research integrity to such an extent that the topic became a field of research itself. Yet, a comprehensive overview of research in the field is still missing. Here we describe methods, trends, publishing patterns, and impact of a decade of research on research integrity.\n\nTo give a comprehensive overview of research on research integrity, we first systematically searched SCOPUS, Web of Science, and PubMed for relevant articles published in English between 2005 and 2015. We then classified each relevant article according to its topic, several methodological characteristics, its general focus and findings, and its citation impact.\n\nWe included 986 articles in our analysis. We found that the body of literature on research integrity is growing in importance, and that the field is still largely dominated by non-empirical publications. Within the bulk of empirical records (N=342), researchers and students are most often studied, but other actors and the social context in which they interact, seem to be overlooked. The few empirical articles that examined determinants of misconduct found that problems from the research system (e.g., pressure, competition) were most likely to cause inadequate research practices. Paradoxically, the majority of empirical articles proposing approaches to foster integrity focused on techniques to build researchers awareness and compliance rather than techniques to change the research system.\n\nOur review highlights the areas, methods, and actors favoured in research on research integrity, and reveals a few blindspots. Involving non-researchers and reconnecting what is known to the approaches investigated may be the first step to generate executable knowledge that will allow us to increase the success of future approaches.\n\nA word from the authorsWe find important to mention that this manuscript underwent peer review and was rejected from the following journals:\n\nO_LIPLOS ONE\nO_LISubmitted 19th December 2017\nC_LIO_LIPeer-review and rejection received 26th June 2018.\nC_LI\nC_LIO_LIJournal of Science and Engineering Ethics (JSEE)\nO_LISubmitted 18th August 2018\nC_LIO_LIPeer-review response with major revision request received 9th September 2019\nC_LIO_LIRevision submitted 24th October 218\nC_LIO_LIRejection received 27th December 2018\nC_LI\nC_LI\n\nWe regret not having submitted this preprint before our first submission. Nonetheless, now after over one year in submission processes, we thought that we should make this manuscript and its data available as a pre-print before undergoing further submissions.\n\nIn order to promote transparency however, we asked both journal whether anonymous reviews could be added alongside this pre-print to ensure that readers are informed of the issues that disqualified our manuscript.\n\nPLOS ONE agreed for us to share the anonymous reviews which are now available -- together with our itemized changes and responses -- in the Online Resource 5 - Peer Review Report. We thank the editors of the Journal of Science and Engineering Ethics and the integrity team of Springer Nature for thoroughly discussing our request, but unfortunately, given the closed peer review policy at Springer Nature, we were unable to provide information about the peer review from the Journal of Science and Engineering Ethics.\n\nWe advise our readers to look at the peer-review and be aware of the challenges and limitations attached with our work. Of course, we welcome comments and contributions to make our work better.\n\nSincerely,\n\nNoemie Aubert Bonn and Wim Pinxten

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Aubert Bonn, N., Pinxten, W.. 2019-03-05. A decade of empirical research on research integrity: what have we (not) looked at?. https://doi.org/10.1101/567263

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Evaluating Large Language Models as Tools to Navigate Researchers in Rapidly Evolving Research Landscapes: A Case Study in Cancer Drug Response Prediction

Large Language Models (LLMs) have emerged as promising tools for assisting researchers in automating and accelerating the synthesis of literature reviews. However, their reliability is a significant concern due to issues like factual inaccuracies and hallucinations. The key question is whether LLMs can reliably provide comprehensive, up-to-date overviews and analyses. This study evaluates the performance of three leading LLMs (OpenAI's ChatGPT, Google's Gemini, and DeepSeek) on the complex task of generating a comprehensive survey paper on deep learning for cancer Drug Response Prediction (DRP). By testing both standard and Deep Research (DR) / Deep Think (DT) modes of LLMs with prompts of varying detail, this paper assesses key academic dimensions, including reference management, content quality, and analytical depth. Key findings reveal that while DR modes of LLMs significantly improve reliability by eliminating hallucinations, performance variations exist across models and prompts. A trade-off between reference quantity and integration quality was observed, and even the best-performing models lacked the analytical depth of human experts, often requiring extensive human supervision. The study concludes that LLMs currently serve as powerful assistive tools but still cannot replace the critical validation and synthesis provided by human researchers. Choosing the best LLM to use depends on the task in hand, while several strategies can be implemented to improve the produced output.

scientific communication and education

Risk factors associated with loss of hepatitis B virus surface antibody in patients with HBV surface-antigen negative/surface antibody positive serostatus receiving biologic DMARDs to treat rheumatic diseases - a nested case-control study

ObjectivesTo elucidate risk factors for loss of hepatitis B virus (HBV) surface antibody (anti-HBs) in patients with rheumatic diseases and HBV surface-antigen negative/anti-HBs positive (HBsAg-/anti-HBs+) serostatus during biologic disease-modifying anti-rheumatic drug (DMARD) treatment.\n\nMethodsThis nested case-control study prospectively enrolled patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis/psoriasis, and juvenile idiopathic arthritis, who were treated with biologic DMARDs from January 2013 to September 2017. The analytic sample included patients with HBsAg-/anti-HBs+ serostatus. Anti-HBs titers were monitored, and cases defined as anti-HBs <10 mIU/mL during follow-up. Cases were matched one-to-all with controls with anti-HBs [&ge;]10 mIU/mL on the same event date and equivalent durations of biologic DMARDs treatment. Between-group characteristics were compared and risk factors for anti-HBs loss elucidated by conditional logistic regression analyses.\n\nResultsAmong 189 enrolled patients, 15 cases were matched with 211 controls. Risk factors associated with anti-HBs loss in multivariate analysis were low baseline anti-HBs titer (adjusted risk ratio = 0.96, 95% CI 0.93-0.99) and chronic kidney disease (adjusted risk ratio = 26.25, 95% CI 1.85-372.35). All cases had baseline anti-HBs titer <100 mIU/mL, and none developed HBV reactivation upon losing anti-HBs.\n\nConclusionsIn addition to low baseline anti-HBs titer, chronic kidney disease is also an independent risk factors associated with loss of anti-HBs in patients with HBsAg-/anti-HBs+ serostatus who receive biologic DMARDs to treat rheumatic diseases.\n\nSignificanceGiven that loss of anti-HBs precedes HBV reactivation and that the use of biologic DMARDs is increasingly widespread nowadays, understanding those who are at risk of loss of anti-HBs is an important and practical clinical issue.\n\nInnovationIn addition to low baseline anti-HBs titer, chronic kidney disease is also an independent risk factors associated with loss of anti-HBs in patients with HBsAg-/anti-HBs+ serostatus who receive biologic DMARDs to treat rheumatic diseases.

scientific communication and education

The Mastery Rubric for Bioinformatics: supporting design and evaluation of career-spanning education and training

As the life sciences have become more data intensive, the pressure to incorporate the requisite training into life-science education and training programs has increased. To facilitate curriculum development, various sets of (bio)informatics competencies have been articulated; however, these have proved difficult to implement in practice. Addressing this issue, we have created a curriculum-design and -evaluation tool to support the development of specific Knowledge, Skills and Abilities (KSAs) that reflect the scientific method and promote both bioinformatics practice and the achievement of competencies. Twelve KSAs were extracted via formal analysis, and stages along a developmental trajectory, from uninitiated student to independent practitioner, were identified. Demonstration of each KSA by a performer at each stage was initially described (Performance Level Descriptors, PLDs), evaluated, and revised at an international workshop. This work was subsequently extended and further refined to yield the Mastery Rubric for Bioinformatics (MR-Bi). The MR-Bi was validated by demonstrating alignment between the KSAs and competencies, and its consistency with principles of adult learning. The MR-Bi tool provides a formal framework to support curriculum building, training, and self-directed learning. It prioritizes the development of independence and scientific reasoning, and is structured to allow individuals (regardless of career stage, disciplinary background, or skill level) to locate themselves within the framework. The KSAs and their PLDs promote scientific problem formulation and problem solving, lending the MR-Bi durability and flexibility. With its explicit developmental trajectory, the tool can be used by developing or practicing scientists to direct their (and their teams) acquisition of new, or to deepen existing, bioinformatics KSAs. The MR-Bi can thereby contribute to the cultivation of a next generation of bioinformaticians who are able to design reproducible and rigorous research, and to critically analyze results from their own, and others, work.

scientific communication and education